预防性 (R,S) - 胺和 (2S,6S) - 氨基胺通过差异调节恐惧神经元组合来降低恐惧表达
Alessia Mastrodonato1, Michelle Jin2, Noelle Kee3
1Department of Psychiatry, Columbia University Irving Medical Center, New York, New York; Division of Systems Neuroscience, Area Neuroscience, Research Foundation for Mental Hygiene, Inc./New York State Psychiatric Institute, New York, New York; MIND Area, Research Foundation for Mental Hygiene, Inc./New York State Psychiatric Institute, New York, New York.
Biological psychiatry
|October 10, 2024
概括
(R,S) - 胺及其代谢物 (2S,6S) - 氨基胺 (HNK) 通过改变特定大脑区域的神经活动来减少学会的恐惧. 这项研究确定了治疗与恐惧有关的疾病的新目标.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 行为科学 行为科学
背景情况:
- 之前的研究表明, (R,S) - 胺和 (2S,6S) - 氨基胺 (HNK) 减弱了学到的恐惧.
- 这些恐惧减轻效应背后的精确神经机制,无论是趋同还是分歧,仍然未确定.
研究的目的:
- 通过 (R,S) - 胺和 (2S,6S) -HNK.来研究与恐惧减弱相关的神经活动模式.
- 为了确定特定的大脑区域和网络变化涉及这些化合物的治疗作用.
主要方法:
- 雄性小鼠在情境恐惧调节范式之前一周内服用 (R,S) - 胺或 (2S,6S) - HNK.
- 在重新暴露于环境后,使用c-fos免疫活性和大规模成像管道来评估大脑活动,以绘制神经网络的地图.
主要成果:
- 无论是 (R,S) - 胺和 (2S,6S) - HNK都成功地减轻了学会的恐惧.
- 在各种大脑区域观察到神经活动的明显和重叠的变化,包括海马体 (背部CA3,腹部CA3,CA1),前额叶皮质 (内膜,前膜),岛内皮质,后皮质,皮形皮质,核团聚,周水管灰色和 thalamus (PVT) 的副腹腔核.
- (R,S) - 胺调节皮层和皮下区域之间的连接性,而 (2S,6S) - HNK增强了这些区域内的连接性.
结论:
- 确定了新的恐惧网络节点,包括核团聚,皮质状皮质,岛内皮质,周水管灰色和后皮质.
- 这些新发现的节点是神经调节策略和制药干预因恐惧引起的疾病的潜在目标.
- 这些发现支持通过更深入地了解它们的神经点来优化现有药物的药物参与和剂量.
相关概念视频
01:24Parenteral Anesthetics: Overview
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
01:20Inhalational Anesthetics: Overview
Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
01:23Sedatives and Hypnotics: Overview
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates these...